# Hyperpolarized Xenon-129 MR Imaging of the Lung

> **NCT04662658** · PHASE1,PHASE2 · RECRUITING · sponsor: **University of Virginia** · enrollment: 24 (estimated)

## Conditions studied

- E-Cig Use

## Interventions

- **DRUG:** Hyperpolarized Xenon -129 MRI

## Key facts

- **NCT ID:** NCT04662658
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-11-05
- **Primary completion:** 2022-12
- **Final completion:** 2025-12
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2020-12-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04662658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04662658, "Hyperpolarized Xenon-129 MR Imaging of the Lung". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04662658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*